White Paper: Developing Antimicrobial Drugs for Resistant Pathogens, Narrow-Spectrum Indications, and Unmet Needs.

Boucher, Helen W; Ambrose, Paul G; Chambers, H F; Ebright, Richard H; Jezek, Amanda; Murray, Barbara E; Newland, Jason G; Ostrowsky, Belinda; Rex, John H

Boucher, Helen W; Ambrose, Paul G; Chambers, H F; Ebright, Richard H; Jezek, Amanda; Murray, Barbara E; Newland, Jason G; Ostrowsky, Belinda; Rex, John H.

Afiliação

Boucher HW; Division of Geographic Medicine and Infectious Diseases, Tufts Medical Center and Tufts University School of Medicine.
Ambrose PG; Institute for Clinical Pharmacodynamics, Schenectady.
Chambers HF; University of California at San Francisco.
Ebright RH; Rutgers University, Piscataway, New Jersey.
Jezek A; Infectious Diseases Society of America, Arlington, Virginia.
Murray BE; Division of Infectious Diseases, University of Texas Medical School at Houston.
Newland JG; St Louis Children's Hospital, Missouri.
Ostrowsky B; Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, New York.
Rex JH; CARB-X, Boston, Massachusetts.

J Infect Dis ; 216(2): 228-236, 2017 07 15.

Article em En | MEDLINE | ID: mdl-28475768

Assuntos

Antibacterianos/farmacologia; Descoberta de Drogas/tendências; Farmacorresistência Bacteriana Múltipla; Bactérias Gram-Negativas/patogenicidade; Animais; Humanos; Ensaios Clínicos Controlados Aleatórios como Assunto; Projetos de Pesquisa

Palavras-chave

antibiotic development; antimicrobial resistance

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Farmacorresistência Bacteriana Múltipla / Descoberta de Drogas / Bactérias Gram-Negativas / Antibacterianos Tipo de estudo: Clinical_trials Limite: Animals / Humans Idioma: En Revista: J Infect Dis Ano de publicação: 2017 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google